Teva, Takeda Announce Agreement for Glatiramer Acetate for MSTreatment in Japan
December 04, 2013 at 06:07 AM EST
Teva Pharmaceutical Industries (NYSE: TEVA ) and Takeda Pharmaceutical Company (OTC: TKPYY ) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the
